The Hedgehog signaling pathway--implications for drug targets in cancer and neurodegenerative disorders
- PMID: 12831321
- DOI: 10.1517/phgs.4.4.411.22751
The Hedgehog signaling pathway--implications for drug targets in cancer and neurodegenerative disorders
Abstract
The Hedgehog (Hh) pathway is a highly conserved signaling cascade involved in many developmental processes. Among others, these include patterning of the ventral neural tube and establishment of left-right asymmetry of the embryo. Additionally, the pathway regulates the development of numerous tissues and cell types. Mutations in elements of the pathway are associated with congenital diseases and defects, and ectopic Hh signaling activity is implicated in the development of a number of neoplasms. While little is known of Hh signaling function in the adult organism, a role of the pathway in maintenance of adult organs and cell types, including several neuronal subtypes in the central nervous system, is beginning to emerge. Elements of the Hh pathway are therefore potential drug targets for the treatment of cancers and degenerative diseases like Parkinson's disease, and the recent isolation of synthetic molecules capable of modulating the activity of the Hh cascade through a direct interaction with elements of the pathway is promising.
Similar articles
-
The hedgehog signaling pathway in cancer.Clin Cancer Res. 2006 Oct 15;12(20 Pt 1):5924-8. doi: 10.1158/1078-0432.CCR-06-1736. Clin Cancer Res. 2006. PMID: 17062662 Review.
-
Mechanisms of Hedgehog pathway activation in cancer and implications for therapy.Trends Pharmacol Sci. 2009 Jun;30(6):303-12. doi: 10.1016/j.tips.2009.03.007. Epub 2009 May 13. Trends Pharmacol Sci. 2009. PMID: 19443052 Review.
-
Translation of developmental biology into therapeutics: the hedgehog signaling pathway and neurodegenerative diseases.Curr Opin Investig Drugs. 2002 Dec;3(12):1742-4. Curr Opin Investig Drugs. 2002. PMID: 12528310 Review. No abstract available.
-
Proteins of the Hedgehog signaling pathway as therapeutic targets against cancer.Expert Rev Proteomics. 2010 Aug;7(4):601-12. doi: 10.1586/epr.10.39. Expert Rev Proteomics. 2010. PMID: 20653513 Review.
-
Hedgehog pathway agonism: therapeutic potential and small-molecule development.ChemMedChem. 2014 Jan;9(1):27-37. doi: 10.1002/cmdc.201300358. Epub 2013 Nov 7. ChemMedChem. 2014. PMID: 24203435 Review.
Cited by
-
Influence of glutathione-S-transferase (GSTM1, GSTP1, GSTT1) and cytochrome p450 (CYP1A1, CYP2D6) polymorphisms on numbers of basal cell carcinomas (BCCs) in families with the naevoid basal cell carcinoma syndrome.J Med Genet. 2006 Apr;43(4):e16. doi: 10.1136/jmg.2005.035006. J Med Genet. 2006. PMID: 16582078 Free PMC article.
-
Frequent deregulations in the hedgehog signaling network and cross-talks with the epidermal growth factor receptor pathway involved in cancer progression and targeted therapies.Pharmacol Rev. 2010 Sep;62(3):497-524. doi: 10.1124/pr.109.002329. Pharmacol Rev. 2010. PMID: 20716670 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical